|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-27.92% | -62.93% |
| Apr. 11 | Syncona to Sell Stake in Portfolio Company to Century Therapeutics | MT |
| Feb. 20 | Syncona’s Takeover of Freeline Therapeutics Becomes Effective | MT |
Myriad Group AG announced Olivier Bartholot in its newly created role of Chief Revenue Officer. Bartholot will be responsible for all sales and revenue generation across the company. In his previous role within Myriad, Bartholot served as VP Corporate Development and was instrumental in building strong relationships with Facebook, Twitter and Yahoo.
Bartholot will continue to be based in Myriad's San Francisco office.
| 1st Jan change | Capi. | |
|---|---|---|
| -62.93% | 0 | |
| +10.52% | 3,085B | |
| +8.91% | 85.92B | |
| +5.14% | 77.91B | |
| -16.20% | 52.89B | |
| +26.18% | 48.28B | |
| +28.93% | 45.38B | |
| -34.05% | 40.83B | |
| +66.72% | 38.78B | |
| -0.36% | 27.48B |
MYRIAD GROUP AG 
